Hong Kong Entropy Maker Share Limited – Trademark Portfolio

Entity Type: 16

Hong Kong Entropy Maker Share Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include DRTONYOS. The owner is based in Sanpokong, Kowloon.

No. 99 King Fuk Street

Rm D07,8/F,Kai Tak Fty Building

Sanpokong, Kowloon 999077 , HK

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WTYSW
WTYSW
Pending 2026
DRTONYOS
DRTONYOS
Registered 2025

Trademark Classifications

Hong Kong Entropy Maker Share Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Hong Kong Entropy Maker Share Limited have?

Hong Kong Entropy Maker Share Limited has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Hong Kong Entropy Maker Share Limited file in?

Hong Kong Entropy Maker Share Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Hong Kong Entropy Maker Share Limited's most well-known trademarks?

Hong Kong Entropy Maker Share Limited's registered trademark portfolio includes well-known marks such as DRTONYOS. These are among 1 currently registered trademark in the portfolio.

What is Hong Kong Entropy Maker Share Limited's trademark registration success rate?

Hong Kong Entropy Maker Share Limited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.